Elevation Wealth Partners’s Sanofi SNY Stock Holding History

Elevation Wealth Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$54.4K	–	370
2023 Q1	$54.4K	Buy	+1,000	New	+$48.6K	0.05%	145

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Elevation Wealth Partners's SNY Position: Q2 2023 in Review

Elevation Wealth Partners sold out of Sanofi (SNY) in Q2 2023, closing a stake of 1,000 shares — an estimated $54.4K sold.

Elevation Wealth Partners first reported a position in SNY in Q1 2023 and held it in 1 quarter. The position peaked at $54.4K in Q1 2023. 672 funds tracked by Wall St. Rank hold SNY as of Q2 2023.

Elevation Wealth Partners reported no remaining Sanofi position as of Q2 2023 after selling out during the quarter.
Elevation Wealth Partners sold 1,000 Sanofi shares in Q2 2023, an estimated $54.4K.
Elevation Wealth Partners first reported a position in Sanofi in Q1 2023 and held it in 1 quarter.
Elevation Wealth Partners's Sanofi position peaked at $54.4K in Q1 2023.
672 funds tracked by Wall St. Rank held Sanofi as of Q2 2023.

Based on Elevation Wealth Partners's 13F filing for Q2 2023, filed 6 Jul 2023.